O99.323
Drug use complicating pregnancy, third trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code O99.323 refers to cases where drug use complicates pregnancy specifically during the third trimester. This classification helps healthcare professionals document and manage issues related to substance use that can affect both the mother and the developing baby during late pregnancy. Recognizing and addressing drug use during this critical period is vital for ensuring the health and safety of both mother and child.
Causes & Symptoms
Clinical Causes: Use of illicit drugs such as cocaine, heroin, or methamphetamine during pregnancy Misuse of prescription medications, including opioids, benzodiazepines, or stimulants Substance dependency or addiction that develops or persists during pregnancy Lack of access to or refusal of substance abuse treatment Psychosocial factors such as stress, mental health issues, or social environment contributing to drug use
Key Symptoms: Signs of drug intoxication or withdrawal in the mother Unexplained weight loss or gain Poor nutritional status Repeated pregnancy complications such as preterm labor or placental abruption Physical symptoms like hypertension or abnormal heart rate Potential fetal signs like growth restriction or abnormal fetal heart rhythms
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive review of the mother’s medical history, including substance use. Healthcare providers may perform screening tests such as urine drug screens, blood tests, or hair analysis to confirm drug use. Monitoring fetal health through ultrasounds and non-stress tests can help identify any adverse effects on the baby. It is essential to evaluate the extent, type, and frequency of drug use to formulate an effective management plan.
Treatment Protocols: Medication-assisted treatment (MAT) to reduce withdrawal symptoms and cravings Counseling and behavioral therapies to address underlying mental health conditions Nutritional support and prenatal care to optimize maternal health Close fetal monitoring to detect and manage potential complications Patient education on the risks associated with drug use and strategies for cessation Development of a support system for ongoing recovery and relapse prevention
Clinical Advice & FAQs
Billing Guidance
Is O99.323 a billable ICD-10 code?
Yes, O99.323 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O99.323?
Clinical documentation must specify the nature of Drug use complicating pregnancy, third trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference